Recount of Prostaglandin E1 Therapy in a Patient With Raynaud's Phenomenon

Journal of the American Osteopathic Association, The - United States
doi 10.7556/jaoa.1995.95.10.572a
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Osteopathic Association

Related search

A Multiclinic, Placebo-Controlled, Double-Blind Study of Prostaglandin E1 in Raynaud's Syndrome.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1985English

Raynaud's Phenomenon

Nurse Prescribing
2017English

A Woman With Dysphagia and Raynaud's Phenomenon

Postgraduate Medical Journal
Medicine
2002English

Effect of Prostaglandins I2 and E1 on Red Cell Deformability in Patients With Raynaud's Phenomenon and Systemic Sclerosis.

BMJ
1981English

Prostaglandins I2 and E1 and Red Cell Deformability in Raynaud's Phenomenon and Systemic Sclerosis

BMJ
1981English

Prostaglandin E1 Therapy in Patients of Congenital Heart Disease With Pulmonary Atresia

The KITAKANTO Medical Journal
1994English

Patient Perceptions of the Raynaud's Condition Score Diary Provide Insight Into Its Performance in Clinical Trials of Raynaud's Phenomenon

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Raynaud's Phenomenon in Pediatric Age

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2011English

Side Effects of Therapy With Prostaglandin E1 in Infants With Critical Congenital Heart Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy